Subtle involuntary movements are not reliable indicators of incipient Huntington's disease

被引:0
作者
de Boo, G
Tibben, A
Hermans, J
Maat, A
Roos, RAC
机构
[1] Leiden Univ, Med Ctr, Dept Neurol, NL-2300 RC Leiden, Netherlands
[2] Leiden Univ, Med Ctr, Dept Med Stat, NL-2300 RC Leiden, Netherlands
[3] Leiden Univ, Med Ctr, Dept Clin Genet, NL-2300 RC Leiden, Netherlands
[4] Univ Hosp Dijkzigt, NL-3015 GD Rotterdam, Netherlands
[5] Erasmus Univ, Dept Clin Genet, NL-3000 DR Rotterdam, Netherlands
[6] Erasmus Univ, Dept Med Psychol & Psychotherapy, NL-3000 DR Rotterdam, Netherlands
关键词
assessments; Huntington's disease; predictive genetic diagnosis; motor symptoms and signs; observer agreement; choreic movements;
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In the past, Huntington's disease was diagnosed when movement disturbances were present in concordance with a positive family history, Early motor signs, however, are often not found in a standard neurologic examination, and their expression is variable. Not until later stages of the disease could one be sure about the diagnosis. Since genetic diagnosis became available, the onset of sym,toms and signs could be studied in the earliest phase. The aim of the study was to evaluate observer agreement of the assessment of early motor signs in Huntington's disease. A total of 17 gene carriers, 22 noncarriers, and eight partners were recorded on video performing several facial movements after instruction and engaging in a 5-minute conversation. Three experienced neurologists, unaware of the genetic status of the participants, judged and classified the video recordings independently. The cases with disagreement were judged a second time after the neurologists discussed these cases. The observer agreement after the first judgment is poor (kappas 0.09, 0.24, 0.45) and after the second judgment satisfactory (kappas 0.79, 0.90, 0.78). Con sequences for clinical practice and research programs into early symptoms and signs are discussed.
引用
收藏
页码:96 / 99
页数:4
相关论文
共 50 条
[41]   Astrocytes and Huntington's Disease [J].
Khakh, Baljit S. ;
Sofroniew, Michael V. .
ACS CHEMICAL NEUROSCIENCE, 2014, 5 (07) :494-496
[42]   Huntington's Disease Genetics [J].
Myers R.H. .
NeuroRX, 2004, 1 (2) :255-262
[43]   The energetics of Huntington's disease [J].
Browne, SE ;
Beal, MF .
NEUROCHEMICAL RESEARCH, 2004, 29 (03) :531-546
[44]   The hypothalamus in Huntington's disease [J].
Bellosta-Diago, Elena ;
Viloria-Alebesque, Alejandro ;
Santos-Lasaosa, Sonia ;
Lopez del Val, Luis Javier .
REVISTA DE NEUROLOGIA, 2017, 65 (09) :415-422
[45]   Bradykinesia in Huntington's disease [J].
Ruiz, PJG ;
Tortosa, EG ;
Bernados, VS ;
Rojo, A ;
Fontán, A ;
de Yebenes, JG .
CLINICAL NEUROPHARMACOLOGY, 2000, 23 (01) :50-52
[46]   Hypochondriasis and Huntington's disease [J].
Romero, MA ;
Silva, AF ;
Palha, AP .
ACTAS ESPANOLAS DE PSIQUIATRIA, 2006, 34 (01) :65-66
[47]   Mitochondria in Huntington's disease [J].
Damiano, Maria ;
Galvan, Laurie ;
Deglon, Nicole ;
Brouillet, Emmanuel .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2010, 1802 (01) :52-61
[48]   Neuroinflammation in Huntington's disease [J].
Moeller, Thomas .
JOURNAL OF NEURAL TRANSMISSION, 2010, 117 (08) :1001-1008
[49]   Caspases in Huntington's disease [J].
Mejia, ROS ;
Friedlander, RM .
NEUROSCIENTIST, 2001, 7 (06) :480-489
[50]   Therapeutics in Huntington’s Disease [J].
Annie Killoran ;
Kevin M. Biglan .
Current Treatment Options in Neurology, 2012, 14 :137-149